- Home
- LUMN vs VKTX Comparison
LUMN vs VKTX Comparison
Compare LUMN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMN
- VKTX
- Stock Information
- Founded
- LUMN 1968
- VKTX 2012
- Country
- LUMN United States
- VKTX United States
- Employees
- LUMN N/A
- VKTX N/A
- Industry
- LUMN Telecommunications Equipment
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- LUMN Telecommunications
- VKTX Health Care
- Exchange
- LUMN Nasdaq
- VKTX Nasdaq
- Market Cap
- LUMN 6.3B
- VKTX 5.9B
- IPO Year
- LUMN 1972
- VKTX 2015
- Fundamental
- Price
- LUMN $7.89
- VKTX $52.59
- Analyst Decision
- LUMN Hold
- VKTX Strong Buy
- Analyst Count
- LUMN 8
- VKTX 11
- Target Price
- LUMN $3.84
- VKTX $109.73
- AVG Volume (30 Days)
- LUMN 18.8M
- VKTX 6.2M
- Earning Date
- LUMN 11-05-2024
- VKTX 10-23-2024
- Dividend Yield
- LUMN N/A
- VKTX N/A
- EPS Growth
- LUMN N/A
- VKTX N/A
- EPS
- LUMN N/A
- VKTX N/A
- Revenue
- LUMN $13,296,000,000.00
- VKTX N/A
- Revenue This Year
- LUMN N/A
- VKTX N/A
- Revenue Next Year
- LUMN N/A
- VKTX N/A
- P/E Ratio
- LUMN N/A
- VKTX N/A
- Revenue Growth
- LUMN N/A
- VKTX N/A
- 52 Week Low
- LUMN $0.97
- VKTX $11.55
- 52 Week High
- LUMN $10.33
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- LUMN 51.81
- VKTX 37.36
- Support Level
- LUMN $7.35
- VKTX $47.65
- Resistance Level
- LUMN $10.33
- VKTX $54.28
- Average True Range (ATR)
- LUMN 0.72
- VKTX 4.07
- MACD
- LUMN -0.17
- VKTX -1.31
- Stochastic Oscillator
- LUMN 27.01
- VKTX 21.70
About LUMN Lumen Technologies Inc.
With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 has shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.